1.845
price up icon0.54%   0.005
 
loading
Schlusskurs vom Vortag:
$1.85
Offen:
$1.83
24-Stunden-Volumen:
8,483
Relative Volume:
0.32
Marktkapitalisierung:
$10.03M
Einnahmen:
$2.35M
Nettoeinkommen (Verlust:
$-2.56M
KGV:
-4.1174
EPS:
-0.4481
Netto-Cashflow:
-
1W Leistung:
+1.38%
1M Leistung:
+5.03%
6M Leistung:
-7.00%
1J Leistung:
-23.14%
1-Tages-Spanne:
Value
$1.83
$1.89
1-Wochen-Bereich:
Value
$1.81
$1.94
52-Wochen-Spanne:
Value
$1.50
$2.87

Immuron Limited Adr Stock (IMRN) Company Profile

Name
Firmenname
Immuron Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
7
Name
Twitter
@ImmuronLtd
Name
Nächster Verdiensttermin
2024-08-27
Name
Neueste SEC-Einreichungen
Name
IMRN's Discussions on Twitter

Vergleichen Sie IMRN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMRN
Immuron Limited Adr
1.88 10.03M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.10 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.01 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.79 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
559.96 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.88 28.51B 3.81B -644.79M -669.77M -6.24

Immuron Limited Adr Aktie (IMRN) Neueste Nachrichten

pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com

Jun 04, 2025
pulisher
May 30, 2025

Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.

May 30, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire

Oct 04, 2024
pulisher
Sep 05, 2024

Immuron: US FDA provides favourable feedback ahead of investigational new drug application for IMM-529 - Proactive financial news

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire

Jul 02, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 07, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK

Mar 07, 2024
pulisher
May 16, 2023

Immuron Limited Announces Participation in the LD Micro Invitational XIII - The Kingston Whig-Standard

May 16, 2023
pulisher
Dec 01, 2022

Immuron Surges On U.S. DoD Funding For Travelan Research By Investing.com - Investing.com Nigeria

Dec 01, 2022
pulisher
Jul 26, 2022

Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan

Jul 26, 2022
pulisher
Jan 19, 2022

Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq

Jan 19, 2022
pulisher
Sep 10, 2020

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

Sep 10, 2020
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Jun 07, 2018

IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors

Jun 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017

Finanzdaten der Immuron Limited Adr-Aktie (IMRN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.48
price down icon 0.20%
$35.88
price down icon 0.20%
$20.84
price up icon 1.97%
$100.80
price up icon 1.27%
$107.04
price up icon 0.32%
biotechnology ONC
$245.98
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):